Skip to main content

Table 2 QuantiFeron (QFN) SARS-CoV-2 test positivity according to the vaccination schedule

From: Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections

QFN SARS-CoV-2

Uninfected population

Infected population

Baseline

1st dose

2nd dose

Baseline

1st dose

2nd dose

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Negative

23 (100.0)

12 (52.2)

1 (0.0)

13 (41.9)

1 (3.9)

0 (0.0)

Positive

0 (0.0)

11 (47.8)

22 (95.7)

18 (58.1)

24 (92.3)

20 (95.2)

Intermediate *

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.9)

1 (4.8)

  1. *Intermediate refers to when the SARS-CoV-2 response and mitogen cannot be detected
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us